Migraine patients abusing ergotamine often have chronic daily headaches ass
ociated with tiredness, sleep and memory disturbances, and reduced general
well-being. We quantified psychological and cognitive functioning in 12 mig
raine patients with and 12 without ergotamine abuse (greater than or equal
to 5 days/week for greater than or equal to 6 months) and 12 healthy contro
ls. Psychological functioning assessed by Symptom Checklist-90 (SCL-90) and
Profile Of Mood State (POMS), was impaired in ergotamine abusers compared
to healthy controls. Cognitive functioning divided into four domains: atten
tion (critical flicker frequency analysis and mental control subscale of th
e Wechsler Memory Scale (WMS), speed of information processing (reaction ti
me tasks and lexical decision tasks), memory (four subscales of the WMS) an
d cognitive flexibility (trailmaking test and WMS digits backwards), was im
paired in ergotamine abusers in speed of information processing and cogniti
ve flexibility. These differences disappeared after correction for total SC
L-90 scores. In conclusion, ergotamine abuse is associated with high psycho
logical distress but not with structural impaired cognitive functioning.